Published in J Invest Dermatol on November 01, 1986
Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med (1998) 7.07
H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem (1988) 4.06
Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem (1986) 3.67
Delayed childbearing and the outcome of pregnancy. N Engl J Med (1990) 3.05
Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis. JAMA (2001) 3.03
From twin to singleton. BMJ (1996) 2.79
Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol (1991) 2.79
Psychosocial influences on mortality after myocardial infarction. N Engl J Med (1984) 2.72
A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med (1994) 2.71
Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet (1996) 2.45
Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. J Biol Chem (1985) 2.45
Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. J Thorac Cardiovasc Surg (2001) 2.44
Calcium regulation of cell-cell contact and differentiation of epidermal cells in culture. An ultrastructural study. Exp Cell Res (1983) 2.43
Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures. Biochemistry (1977) 2.39
Successful repair in utero of a fetal diaphragmatic hernia after removal of herniated viscera from the left thorax. N Engl J Med (1990) 2.17
Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol (1992) 2.14
Collagenase production by human skin fibroblasts. Biochem Biophys Res Commun (1975) 2.12
Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol (1986) 2.10
Pregnancy outcome at age 40 and older. Obstet Gynecol (1996) 2.09
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biol Blood Marrow Transplant (2013) 2.04
First-trimester screening for aneuploidy: research or standard of care? Am J Obstet Gynecol (2000) 2.00
Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol (2000) 1.97
Assembly of stratum corneum basic protein and keratin filaments in macrofibrils. Nature (1978) 1.96
Rates of and risk factors for trichomoniasis among pregnant inmates in New York City. Sex Transm Dis (1998) 1.92
Characterization of Soybean Plasma Membrane during Development: FREE STEROL COMPOSITION AND CONCANAVALIN A BINDING STUDIES. Plant Physiol (1980) 1.90
Fetal echocardiography. A tool for evaluation of in utero cardiac arrhythmias and monitoring of in utero therapy: analysis of 71 patients. Am J Cardiol (1983) 1.89
Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci U S A (1987) 1.89
International, collaborative experience of 1789 patients having multifetal pregnancy reduction: a plateauing of risks and outcomes. J Soc Gynecol Investig (1996) 1.87
Fetal echocardiography for evaluation of in utero congestive heart failure. N Engl J Med (1982) 1.87
Risk factors for severe preeclampsia. Obstet Gynecol (1994) 1.87
American College of Medical Genetics statement of diagnostic testing for uniparental disomy. Genet Med (2001) 1.86
Who should be offered prenatal diagnosis? The 35-year-old question. Am J Public Health (1999) 1.81
Ventricular premature beats and mortality after myocardial infarction. N Engl J Med (1977) 1.79
Marfan syndrome: abnormal alpha 2 chain in type I collagen. Proc Natl Acad Sci U S A (1981) 1.78
Fetal hydrops and death from sacrococcygeal teratoma: rationale for fetal surgery. Am J Obstet Gynecol (1989) 1.74
Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest (1979) 1.73
Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta. J Clin Invest (1983) 1.71
Expression of epidermal keratins and filaggrin during human fetal skin development. J Cell Biol (1985) 1.68
American College of Medical Genetics statement on folic acid: fortification and supplementation. Am J Med Genet (1998) 1.68
Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. Proc Natl Acad Sci U S A (1991) 1.66
Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. Proc Natl Acad Sci U S A (1985) 1.65
Are women who are Jehovah's Witnesses at risk of maternal death? Am J Obstet Gynecol (2001) 1.65
X-linked cutis laxa: defective cross-link formation in collagen due to decreased lysyl oxidase activity. N Engl J Med (1980) 1.62
Prenatal diagnosis of fetal cytomegalovirus infection. Am J Obstet Gynecol (1991) 1.62
Ultrasound in the diagnosis of congenital anomalies. Am J Obstet Gynecol (1979) 1.59
Successful treatment of painful crises of Fabry disease with low dose morphine. Pediatr Neurol (1995) 1.58
Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase. N Engl J Med (1980) 1.58
Lead time in breast cancer detection and implications for periodicity of screening. Am J Epidemiol (1974) 1.56
Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents. Am J Obstet Gynecol (1988) 1.54
Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer. Magn Reson Med (2011) 1.53
High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis? Obstet Gynecol (1990) 1.53
Fabry disease: twenty-three mutations including sense and antisense CpG alterations and identification of a deletional hot-spot in the alpha-galactosidase A gene. Hum Mol Genet (1994) 1.52
Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. N Engl J Med (1981) 1.52
Improvement in outcomes of multifetal pregnancy reduction with increased experience. Am J Obstet Gynecol (2001) 1.50
Infection following breast reconstruction. Ann Plast Surg (1989) 1.50
Antenatal treatment of alloimmune thrombocytopenia. Obstet Gynecol (1992) 1.49
Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr (2000) 1.48
Ultrasonographic screening for the Down syndrome fetus. Am J Obstet Gynecol (1991) 1.48
Human skin fibroblast collagenase: chemical properties of precursor and active forms. Biochemistry (1978) 1.47
Physical activity and the risk of spontaneous preterm delivery. J Reprod Med (1983) 1.46
Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts. Lab Invest (1981) 1.46
Comparison of endovascular and conventional vascular prostheses in an experimental infection model. J Vasc Surg (1996) 1.45
Transabdominal versus transcervical and transvaginal multifetal pregnancy reduction: international collaborative experience of more than one thousand cases. Am J Obstet Gynecol (1994) 1.43
First trimester growth delay in trisomy 18. Am J Perinatol (1989) 1.42
Chorionic villus sampling before multifetal pregnancy reduction. Am J Obstet Gynecol (2000) 1.40
Teratogen exposure: lack of morphological abnormalities by detailed fetal sonography. Ultrasound Obstet Gynecol (1994) 1.38
Enzyme-linked immunosorbent assay for human skin collagenase. Coll Relat Res (1983) 1.38
A specific inhibitor of vertebrate collagenase produced by human skin fibroblasts. J Biol Chem (1979) 1.37
The ultrasonic changes in the maturing placenta and their relation to fetal pulmonic maturity. Am J Obstet Gynecol (1979) 1.36
Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome. Lab Invest (1979) 1.36
Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program. Blood Cells (1994) 1.35
Outcome of fetal ventriculomegaly. Lancet (1984) 1.35
Heterozygosity for a large deletion in the alpha 2(I) collagen gene has a dramatic effect on type I collagen secretion and produces perinatal lethal osteogenesis imperfecta. J Biol Chem (1988) 1.34
Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation). Am J Obstet Gynecol (1983) 1.33
Quantitation and immunocytochemical localization of human skin collagenase in basal cell carcinoma. J Invest Dermatol (1977) 1.33
Clinical and ultrastructural heterogeneity of type IV Ehlers-Danlos syndrome. Hum Genet (1979) 1.31
Human skin collagenase. The role of serum alpha-globulins in the control of activity in vivo and in vitro. Proc Natl Acad Sci U S A (1971) 1.31
Regional differences in the thickness (cell layers) of the human stratum corneum: an ultrastructural analysis. J Invest Dermatol (1974) 1.31
An evaluation of two equations for predicting fetal weight by ultrasound. Am J Obstet Gynecol (1982) 1.30
Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa. Genomics (1994) 1.28
Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. Arthritis Rheum (1995) 1.28
The assembly of laminin-5 subunits. J Biol Chem (1995) 1.24
Fetal cystic hygroma. Cause and natural history. N Engl J Med (1983) 1.23
Heterogeneity in harlequin ichthyosis, an inborn error of epidermal keratinization: variable morphology and structural protein expression and a defect in lamellar granules. J Invest Dermatol (1990) 1.23
Immunolocalization of epidermal growth factor receptors in normal developing human skin. J Invest Dermatol (1990) 1.23
The fine structure of developing human epidermis: light, scanning, and transmission electron microscopy of the periderm. J Invest Dermatol (1975) 1.23
Conjoined twins: prenatal diagnosis and assessment of associated malformations. Radiology (1990) 1.23
Genetic disorders of collagen metabolism. Adv Hum Genet (1982) 1.22
Topical ocular antibiotics induce bacterial resistance at extraocular sites. Br J Ophthalmol (2005) 1.22
Structural abnormalities in the dermal collagen and elastic matrix from the skin of patients with inherited connective tissue disorders. J Invest Dermatol (1982) 1.22
Fetal alloimmune thrombocytopenia. N Engl J Med (1997) 1.21
Melanoma growth-stimulatory activity/GRO decreases collagen expression by human fibroblasts. Regulation by C-X-C but not C-C cytokines. J Biol Chem (1993) 1.21
Recessive dystrophic epidermolysis bullosa phenotype is preserved in xenografts using SCID mice: development of an experimental in vivo model. J Invest Dermatol (1992) 1.20
Combined pregnancy: the Mount Sinai experience. Obstet Gynecol Surv (1986) 1.20
Palmar-plantar keratoderma. A clinical, ultrastructural, and biochemical study. J Am Acad Dermatol (1988) 1.20
Perinatal outcome in grand and great-grand multiparity: effects of parity on obstetric risk factors. Am J Obstet Gynecol (1999) 1.19
Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence. Urology (2001) 1.17